MetLife, Inc. MET
97.70
0.45
0.46%
as of 25 Sep
- Market cap
- $61.6B
- P/E
- 18.7×
Follow MET
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
15.51 | 16.80 | 13.71 | 16.21 |
P/S ratio |
0.76 | 0.69 | 0.59 | 0.68 | |
P/FCF ratio |
3.74 | 3.09 | 2.97 | 3.49 | |
P/Operating CF |
15.35 | 7.46 | 17.16 | 24.40 | |
P/B ratio |
1.88 | 1.84 | 1.67 | 1.96 | |
Price to Tangible BV |
2.72 | 2.77 | 2.56 | 2.99 | |
EV/Sales |
0.76 | 0.65 | 0.56 | 0.70 | |
EV/EBITDA |
11.12 | 10.75 | 9.08 | 11.34 | |
EV/Operating CF |
3.74 | 2.93 | 2.82 | 3.55 | |
EV/FCF |
3.74 | 2.93 | 2.82 | 3.55 | |
Quick Ratio |
0.13 | 0.15 | 0.15 | 0.15 | |
Current Ratio |
0.13 | 0.15 | 0.15 | 0.15 | |
Net Debt/EBITDA |
0.00 | (2.42) | (1.59) | 0.80 | |
Debt/Assets |
2.81% | 2.59% | 2.73% | 2.65% | |
Debt/Equity |
0.69 | 0.67 | 0.74 | 0.73 | |
Asset Turnover |
0.10 | 0.11 | 0.11 | 0.11 | |
Operating CF/Net income |
4.36 | 9.10 | 2.36 | 3.16 | |
Capex/Depreciation |
— | 0.00 | — | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(11.50) | (12.21) | (13.93) | (12.16) | |
Graham Number |
72.44 | 67.34 | 70.10 | 71.21 | |
Earnings Yield |
6.45% | 5.95% | 7.30% | 6.17% | |
Free Cash Flow Yield |
26.72% | 32.37% | 33.65% | 28.61% | |
Revenue per Share |
26.12 | 35.60 | 29.25 | 29.81 | |
Operating CF per Share |
5.37 | 10.58 | 4.12 | 3.47 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
5.37 | 10.58 | 4.12 | 3.47 | |
Cash per Share |
30.44 | 32.94 | 34.80 | 30.04 | |
Shareholders Equity per Share |
43.92 | 42.88 | 42.32 | 43.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
43.92 | 42.88 | 42.32 | 43.17 | |
Free Cash Flow |
3,567.00 | 7,076.00 | 2,687.00 | 2,228.00 | |
Working Capital |
(401,392.00) | (401,303.00) | (401,837.00) | (409,993.00) | |
Net Current Asset Value |
(629,599.00) | (644,735.00) | (642,139.00) | (661,269.00) | |
EV/EBIT |
11.12 | 10.75 | 9.08 | 11.34 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
4.71% | 3.27% | 5.98% | 3.68% | |
Price to Operating Income |
11.12 | 11.33 | 9.58 | 11.17 | |
| Other line items | |||||
Average Receivables |
36,225.00 | 39,887.50 | 41,189.50 | 41,559.00 | |
Average Payables |
223,627.00 | 223,599.00 | 225,160.50 | 225,616.50 | |
Average Assets |
712,351.00 | 711,311.50 | 715,763.50 | 730,921.00 | |
Average Common Equity |
30,177.50 | 28,191.50 | 27,675.00 | 27,834.00 |
Columns are period end dates